{"content":"<li class=\"n-box-item date-title\" data-end=\"1573880399\" data-start=\"1573794000\" data-txt=\"Monday, December 23, 2019\">Friday, November 15, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3519954\" data-ts=\"1573858321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519954-acb-sig-and-rlgy-among-notable-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ACB, AM, SIG and RLGY among notable after hours movers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/STKL' title='SunOpta Inc.'>STKL</a> <font color=\"green\">+3.3%</font>. <a href='https://seekingalpha.com/symbol/NIU' title='Niu Technologies'>NIU</a> <font color=\"green\">+2.5%</font>. <a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color=\"green\">+2.2%</font>. <a href='https://seekingalpha.com/symbol/STRA' title='Strategic Education, Inc.'>STRA</a> <font color=\"green\">+1.3%</font>. <a href='https://seekingalpha.com/symbol/AM' title='Antero Midstream Corporation'>AM</a> <font color=\"green\">+1.1%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings Corp.'>RLGY</a> <font color=\"red\">-3.5%</font>. <a href='https://seekingalpha.com/symbol/DERM' title='Dermira, Inc.'>DERM</a> <font color=\"red\">-3%</font>. <a href='https://seekingalpha.com/symbol/CURO' title='CURO Group Holdings Corp.'>CURO</a> <font color=\"red\">-3%</font>. <a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a> <font color=\"red\">-2.7%</font>. <a href='https://seekingalpha.com/symbol/LK' title='Luckin Coffee Inc.'>LK</a> <font color=\"red\">-1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519954\" data-linked=\"ACB, AM, SIG and RLGY among notable after hours movers\" data-tweet=\"$STKL $NIU $ACB - ACB, AM, SIG and RLGY among notable after hours movers https://seekingalpha.com/news/3519954-acb-sig-and-rlgy-among-notable-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3519954-acb-sig-and-rlgy-among-notable-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519936\" data-ts=\"1573854067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519936-vxx-mj-ugaz-and-dgaz-among-notable-etf-movers-5-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VXX, MJ, UGAZ and DGAZ among notable ETF movers (5-Day)</a></h4><ul><li><strong>Gainers: </strong>Direxion Natural Gas Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>) <font color=\"green\">+15.6%</font>.</li><li>Natural Gas -3X Inverse ETN Velocityshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>) <font color=\"green\">+13.5%</font>.</li><li>Direxion S&amp;P Oil &amp; Gas Expl Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>) <font color=\"green\">+12.7%</font>.</li><li>Direxion FTSE China Bear 3X (NYSEARCA:<a href='https://seekingalpha.com/symbol/YANG' title='Direxion Daily FTSE China Bear 3x Shares ETF'>YANG</a>) <font color=\"green\">+12.5%</font>.</li><li>Ipath Cocoa Subindex TR Sm Index ETN (NYSEARCA:<a href='https://seekingalpha.com/symbol/NIB' title='iPath Bloomberg Cocoa Subindex Total Return ETN'>NIB</a>) <font color=\"green\">+9.0%</font>.</li><li><strong>Losers: </strong>Global X Cannabis ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/POTX' title='Global X Funds - Global X Cannabis Etf'>POTX</a>) <font color=\"red\">-18.3%</font>.</li><li>Spinnaker ETF Series The Cannabis ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/THCX' title='Spinnaker ETF Series - The Cannabis ETF'>THCX</a>) <font color=\"red\">-16.0%</font>.</li><li>Natural Gas Bull 3X Direxion (NYSEARCA:<a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>) <font color=\"red\">-15.0%</font>.</li><li>Alternative Harvest ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a>) <font color=\"red\">-14.5%</font>.</li><li>Natural Gas 3X Long ETN Velocityshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>) <font color=\"red\">-14.4%</font>.</li><li><strong>Top non-leveraged gainers: </strong>Ipath Cocoa Subindex TR Sm Index ETN (<a href='https://seekingalpha.com/symbol/NIB' title='iPath Bloomberg Cocoa Subindex Total Return ETN'>NIB</a>) <font color=\"green\">+9.0%</font>.</li><li>G-X Nigeria Index ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/NGE' title='Global X MSCI Nigeria ETF'>NGE</a>) <font color=\"green\">+7.3%</font>.</li><li>G-X MSCI Pakistan ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/PAK' title='Global X Funds - Global X MSCI Pakistan ETF'>PAK</a>) <font color=\"green\">+6.3%</font>.</li><li>Purefunds ISE Junior Silver ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/SILJ' title='ETFMG Prime Junior Silver ETF'>SILJ</a>) <font color=\"green\">+3.9%</font>.</li><li>Renaissance IPO ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/IPO' title='Renaissance Capital Greenwich Funds - Renaissance IPO ETF'>IPO</a>) <font color=\"green\">+3.7%</font>.</li><li><strong>Top non-leveraged losers: </strong>Cambria Cannabis ETF (BATS:<a href='https://seekingalpha.com/symbol/TOKE' title='Cambria ETF Trust - Cambria Cannabis ETF'>TOKE</a>) <font color=\"red\">-12.4%</font>.</li><li>Advisorshares Pure Cannabis ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/YOLO' title='AdvisorShares Pure Cannabis ETF'>YOLO</a>) <font color=\"red\">-12.2%</font>.</li><li>Ipath.B S&amp;P 500 VIX Short-Term Futures ETN (BATS:<a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a>) <font color=\"red\">-6.3%</font>.</li><li>VS VIX Short Term (NASDAQ:<a href='https://seekingalpha.com/symbol/VIIX' title='VelocityShares VIX Short-Term ETN'>VIIX</a>)<font color=\"red\"> -6.2%</font>.</li><li>VIX Short-Term Futures Proshares (NYSEARCA:<a href='https://seekingalpha.com/symbol/VIXY' title='ProShares VIX Short-Term Futures ETF'>VIXY</a>) <font color=\"red\">-6.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519936\" data-linked=\"VXX, MJ, UGAZ and DGAZ among notable ETF movers (5-Day)\" data-tweet=\"$GASX $DGAZ $DRIP - VXX, MJ, UGAZ and DGAZ among notable ETF movers (5-Day) https://seekingalpha.com/news/3519936-vxx-mj-ugaz-and-dgaz-among-notable-etf-movers-5-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3519936-vxx-mj-ugaz-and-dgaz-among-notable-etf-movers-5-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519904\" data-ts=\"1573851228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519904-oklahoma-judge-lowers-j-and-js-opioid-epidemic-tab-107m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oklahoma judge lowers J&amp;J&#39;s opioid epidemic tab by $107M</a></h4><ul><li>Saying he miscalculated the cost of treating babies addicted to opioids, Oklahoma judge Thad Balkman has <a href=\"https://apnews.com/f2ca0f4bb033450b8efe109312b4aa93?utm_medium=AP&amp;utm_source=Twitter&amp;utm_campaign=SocialFlow\" target=\"_blank\">reduced </a>Johnson &amp; Johnson's (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"green\">+2.9%</font>) financial commitment over its role in the opioid crisis in the state. The company will now be on the hook for $465M, $107M lower than the initial settlement of $572M, citing an initial estimate of $107M to develop a program which should have been $107K.</li><li>He declined a request by the defendants for a more significant reduction considering the $355M settlement with Purdue Pharma and Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"green\">+8.4%</font>).</li><li>Related tickers: AmerisourceBergen (<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color=\"green\">+1.9%</font>), Cardinal Health (<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health, Inc.'>CAH</a> <font color=\"green\">+2.8%</font>), McKesson (<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color=\"green\">+2.6%</font>), Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"green\">+9%</font>), Mallinckrodt (<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a> <font color=\"green\">+4.3%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3519904\" data-linked=\"Oklahoma judge lowers J&amp;J&#39;s opioid epidemic tab by $107M\" data-tweet=\"$JNJ $TEVA $ABC - Oklahoma judge lowers J&amp;J&#39;s opioid epidemic tab by $107M https://seekingalpha.com/news/3519904-oklahoma-judge-lowers-j-and-js-opioid-epidemic-tab-107m?source=tweet\" data-url=\"https://seekingalpha.com/news/3519904-oklahoma-judge-lowers-j-and-js-opioid-epidemic-tab-107m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519891\" data-ts=\"1573849417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QGEN\" target=\"_blank\">QGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519891-qiagen-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qiagen shares halted pending news</a></h4><ul><li>The NYSE has suspended trading in QIAGEN (<a href='https://seekingalpha.com/symbol/QGEN' title='QIAGEN N.V.'>QGEN</a> <font color=\"green\">+0.3%</font>) pending the release of news. Thermo Fisher Scientific (<a href='https://seekingalpha.com/symbol/TMO' title='Thermo Fisher Scientific Inc.'>TMO</a> <font color=\"green\">+1.7%</font>) is rumored to be a suitor.</li><li><strong>Update</strong>: In a <a href=\"https://seekingalpha.com/pr/17701314-qiagen-receives-several-conditional-non-binding-indications-interest-enters-discussions\" target=\"_blank\">statement</a>, the company says it has received several conditional \"non-binding indications of interest\" and has begun the process of reviewing strategic alternatives, including talks with interested parties.</li><li><strong>Update</strong>: Shares resumed trading at ~3:39 pm ET and are up <font color=\"green\">9%</font> approaching the close.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519891\" data-linked=\"Qiagen shares halted pending news\" data-tweet=\"$QGEN $TMO - Qiagen shares halted pending news https://seekingalpha.com/news/3519891-qiagen-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3519891-qiagen-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519885\" data-ts=\"1573847804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKR\" target=\"_blank\">BKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519885-baker-hughes-upped-susquehanna-on-strong-free-cash-flow-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baker Hughes upped at Susquehanna on strong free cash flow view</a></h4><ul><li>Baker Hughes (<a href='https://seekingalpha.com/symbol/BKR' title='Baker Hughes Company'>BKR</a> <font color='green'>+3.6%</font>) rallies after Susquehanna <a href=\"https://thefly.com/thestreet/realmoney/index.php/BKRid2994859/BKR-Baker-Hughes-upgraded-to-Positive-at-Susquehanna\" target=\"_blank\">upgrades</a> shares to Positive  from Neutral with a $27 price target, ticked up from $25, forecasting compelling earnings growth through 2021  with double digit annual growth in free cash flow.</li><li>Susquehanna analyst Charles Minervino notes a strong  backlog of work in the long cycle Turbomachinery and Process Solutions and Oilfield Equipment businesses.</li><li>Earlier this week, BKR <a href=\"https://www.hydrocarbonengineering.com/petrochemicals/15112019/baker-hughes-begins-construction-of-saudi-arabian-chemical-facility/\" target=\"_blank\">broke ground</a> on its first chemicals manufacturing facility in Saudi Arabia.</li><li>BKR's average <a href=\"https://seekingalpha.com/symbol/BKR/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Bullish, while its <a href=\"https://seekingalpha.com/symbol/BKR/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> and <a href=\"https://seekingalpha.com/symbol/BKR/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> are both Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519885\" data-linked=\"Baker Hughes upped at Susquehanna on strong free cash flow view\" data-tweet=\"$BKR - Baker Hughes upped at Susquehanna on strong free cash flow view https://seekingalpha.com/news/3519885-baker-hughes-upped-susquehanna-on-strong-free-cash-flow-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3519885-baker-hughes-upped-susquehanna-on-strong-free-cash-flow-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519884\" data-ts=\"1573847651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519884-crwd-i-pi-and-logm-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRWD, I, PI and LOGM among tech movers</a></h4><ul><li><strong>Gainers: </strong>nLIGHT (NASDAQ:<a href='https://seekingalpha.com/symbol/LASR' title='nLIGHT, Inc.'>LASR</a>) <font color=\"green\">+18%</font>.</li><li>Intelsat S.A. (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) <font color=\"green\">+13%</font>.</li><li>Digi International (NASDAQ:<a href='https://seekingalpha.com/symbol/DGII' title='Digi International Inc.'>DGII</a>) <font color=\"green\">+12%</font>.</li><li>LogMeIn (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a>) <font color=\"green\">+12%</font>.</li><li>CrowdStrike Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CRWD' title='CrowdStrike Holdings, Inc.'>CRWD</a>) <font color=\"green\">+11%</font>.</li> <li><strong>Losers: </strong>ClearOne (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRO' title='ClearOne, Inc.'>CLRO</a>) <font color=\"red\">-14%</font>.</li><li>Internap Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/INAP' title='Internap Corporation'>INAP</a>) <font color=\"red\">-14%</font>.</li><li>Applied DNA Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a>) <font color=\"red\">-10%</font>.</li><li>Polar Power (NASDAQ:<a href='https://seekingalpha.com/symbol/POLA' title='Polar Power, Inc.'>POLA</a>) <font color=\"red\">-8%</font>.</li><li>Impinj (NASDAQ:<a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3519884\" data-linked=\"CRWD, I, PI and LOGM among tech movers\" data-tweet=\"$LASR $I $DGII - CRWD, I, PI and LOGM among tech movers https://seekingalpha.com/news/3519884-crwd-i-pi-and-logm-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3519884-crwd-i-pi-and-logm-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519883\" data-ts=\"1573846626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519883-petrobras-produces-first-oil-iara-license-offshore-brazil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Petrobras produces first oil at Iara license offshore Brazil</a></h4><ul><li>Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petróleo Brasileiro S.A. - Petrobras'>PBR</a> <font color='green'>+2.1%</font>) says it <a href=\"https://www.ogj.com/drilling-production/article/14072085/petrobras-and-partners-add-presalt-production-in-brazil\" target=\"_blank\">started oil and gas production</a> at the Iara license at Brazil's deepwater pre-salt Santos Basin from the P-68 floating production, storage and offloading  vessel.</li><li>The P-68 FPSO, which can process up to 150K bbl/day of oil and 6M cm of gas, is the first of the two FPSOs already launched and to be installed on  the license and will contribute to PBR's production growth, particularly in 2020,  with new wells being interconnected in the Berbigão field and the  interconnection of wells in Sururu field.</li><li>PBR is the operator and 42.5% owner of the Iara license, in partnership with Royal Dutch Shell (<a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a>, <a href='https://seekingalpha.com/symbol/RDS.B' title='Royal Dutch Shell plc'>RDS.B</a>), which holds a 25% stake, Total (NYSE:<a href='https://seekingalpha.com/symbol/TOT' title='TOTAL S.A.'>TOT</a>) with 22.5% and Petrogal Brasil at 10%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519883\" data-linked=\"Petrobras produces first oil at Iara license offshore Brazil\" data-tweet=\"$PBR $RDS.A $RDS.B - Petrobras produces first oil at Iara license offshore Brazil https://seekingalpha.com/news/3519883-petrobras-produces-first-oil-iara-license-offshore-brazil?source=tweet\" data-url=\"https://seekingalpha.com/news/3519883-petrobras-produces-first-oil-iara-license-offshore-brazil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519878\" data-ts=\"1573844653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519878-noble-corporation-and-propetro-among-energy-materials-gainers-sandridge-permian-trust-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Corporation and ProPetro among Energy/Materials gainers;  SandRidge Permian Trust and Centrus Energy among losers</a></h4><ul><li><b>Gainers: </b>Noble Corporation (NYSE:<a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a>) <font color=\"green\">+9%</font>. ProPetro (NYSE:<a href='https://seekingalpha.com/symbol/PUMP' title='ProPetro Holding Corp.'>PUMP</a>) <font color=\"green\">+9%</font>. Martin Midstream Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/MMLP' title='Martin Midstream Partners L.P.'>MMLP</a>) <font color=\"green\">+8%</font>. California Resources (NYSE:<a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a>) <font color=\"green\">+7%</font>. CSI Compressco (NASDAQ:<a href='https://seekingalpha.com/symbol/CCLP' title='CSI Compressco LP'>CCLP</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>SandRidge Permian Trust (NYSE:<a href='https://seekingalpha.com/symbol/PER' title='SandRidge Permian Trust'>PER</a>) <font color=\"red\">-31%</font>. Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"red\">-10%</font>. Friedman Industries (NYSEMKT:<a href='https://seekingalpha.com/symbol/FRD' title='Friedman Industries, Incorporated'>FRD</a>) <font color=\"red\">-9%</font>. Taronis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TRNX' title='Taronis Technologies, Inc.'>TRNX</a>) <font color=\"red\">-8%</font>. SilverBow Resources (NYSE:<a href='https://seekingalpha.com/symbol/SBOW' title='SilverBow Resources, Inc.'>SBOW</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519878\" data-linked=\"Noble Corporation and ProPetro among Energy/Materials gainers;  SandRidge Permian Trust and Centrus Energy among losers\" data-tweet=\"$NE $PUMP $MMLP - Noble Corporation and ProPetro among Energy/Materials gainers; SandRidge Permian Trust and Centrus Energy among losers https://seekingalpha.com/news/3519878-noble-corporation-and-propetro-among-energy-materials-gainers-sandridge-permian-trust-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3519878-noble-corporation-and-propetro-among-energy-materials-gainers-sandridge-permian-trust-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519952\" data-ts=\"1573842704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMKEF\" target=\"_blank\">NMKEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519952-nemaska-lithium-plans-key-project-shutdown-still-seeks-capital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nemaska Lithium plans key project shutdown, still seeks capital</a></h4><ul><li>Nemaska Lithium (<a href='https://seekingalpha.com/symbol/NMKEF' title='Nemaska Lithium Inc.'>OTCQX:NMKEF</a> <font color='red'>-3.7%</font>) says it will place its Whabouchi project in Quebec <a href=\"https://www.mining.com/nemaska-lithium-shares-hit-new-low-says-project-shutdown-within-weeks/\" target=\"_blank\">on care and maintenance</a> before the end of the year, sending shares to new multi-year lows.</li><li>Nemaska says it is still working with investment firm Pallinghurst and other strategic partners to secure financing for the project.</li><li>As of Aug. 31, the company had incurred C$392M in cost overruns on total project budget of C$1.27B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519952\" data-linked=\"Nemaska Lithium plans key project shutdown, still seeks capital\" data-tweet=\"$NMKEF - Nemaska Lithium plans key project shutdown, still seeks capital https://seekingalpha.com/news/3519952-nemaska-lithium-plans-key-project-shutdown-still-seeks-capital?source=tweet\" data-url=\"https://seekingalpha.com/news/3519952-nemaska-lithium-plans-key-project-shutdown-still-seeks-capital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519872\" data-ts=\"1573842510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTON\" target=\"_blank\">PTON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519872-peloton-gains-again-on-new-products-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peloton gains again on new products development</a></h4><ul> <li>Peloton Interactive (NASDAQ:<a href='https://seekingalpha.com/symbol/PTON' title='Peloton Interactive, Inc.'>PTON</a>) is <font color=\"green\">up 4.65%</font> on the day and is now more than 15% higher for the week as investor latch on to the company's plan to introduce new products next year.</li> <li>Bernstein sees sales upside from the company's introduction of a treadmill to its user base of over 1.6M and to potentially new customers.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3519872\" data-linked=\"Peloton gains again on new products development\" data-tweet=\"$PTON - Peloton gains again on new products development https://seekingalpha.com/news/3519872-peloton-gains-again-on-new-products-development?source=tweet\" data-url=\"https://seekingalpha.com/news/3519872-peloton-gains-again-on-new-products-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519870\" data-ts=\"1573841230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519870-mmtec-leads-financial-gainers-enova-international-and-cpi-card-group-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mmtec leads financial gainers; Enova International and CPI Card Group among losers</a></h4><ul><li><b>Gainers:</b> Mmtec (NASDAQ:<a href='https://seekingalpha.com/symbol/MTC' title='Mmtec, Inc.'>MTC</a>) <font color=\"green\">+35%</font>. Banco de Chile (NYSE:<a href='https://seekingalpha.com/symbol/BCH' title='Banco de Chile'>BCH</a>) <font color=\"green\">+14%</font>. Banco Santander-Chile (NYSE:<a href='https://seekingalpha.com/symbol/BSAC' title='Banco Santander-Chile'>BSAC</a>) <font color=\"green\">+14%</font>. Grupo Supervielle (NYSE:<a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle S.A.'>SUPV</a>) <font color=\"green\">+9%</font>. Atlantic American (NASDAQ:<a href='https://seekingalpha.com/symbol/AAME' title='Atlantic American Corporation'>AAME</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers:</b> Q&amp;K International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/QK' title='Q&K International Group Limited'>QK</a>) <font color=\"red\">-15%</font>. CPI Card Group (NASDAQ:<a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group Inc.'>PMTS</a>) <font color=\"red\">-15%</font>. Enova International (NYSE:<a href='https://seekingalpha.com/symbol/ENVA' title='Enova International, Inc.'>ENVA</a>) <font color=\"red\">-11%</font>. Medley Management (NYSE:<a href='https://seekingalpha.com/symbol/MDLY' title='Medley Management Inc.'>MDLY</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519870\" data-linked=\"Mmtec leads financial gainers; Enova International and CPI Card Group among losers\" data-tweet=\"$MTC $BCH $BSAC - Mmtec leads financial gainers; Enova International and CPI Card Group among losers https://seekingalpha.com/news/3519870-mmtec-leads-financial-gainers-enova-international-and-cpi-card-group-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3519870-mmtec-leads-financial-gainers-enova-international-and-cpi-card-group-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519866\" data-ts=\"1573840854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519866-american-superconductor-among-industrial-gainers-limbach-holdings-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Superconductor among industrial gainers; Limbach Holdings leads the losers</a></h4><ul><li><b>Gainers: </b>Charah Solutions (NYSE:<a href='https://seekingalpha.com/symbol/CHRA' title='Charah Solutions, Inc.'>CHRA</a>) <font color=\"green\">+8%</font>. Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"green\">+7%</font>. American Superconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/AMSC' title='American Superconductor Corporation'>AMSC</a>) <font color=\"green\">+6%</font>. LiqTech International (NASDAQ:<a href='https://seekingalpha.com/symbol/LIQT' title='LiqTech International, Inc.'>LIQT</a>) <font color=\"green\">+6%</font>. Chart Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/GTLS' title='Chart Industries, Inc.'>GTLS</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Limbach Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LMB' title='Limbach Holdings, Inc.'>LMB</a>) <font color=\"red\">-35%</font>. Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"red\">-10%</font>. Griffon (NYSE:<a href='https://seekingalpha.com/symbol/GFF' title='Griffon Corporation'>GFF</a>) <font color=\"red\">-6% </font>NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519866\" data-linked=\"American Superconductor among industrial gainers; Limbach Holdings leads the losers\" data-tweet=\"$CHRA $IPWR $AMSC - American Superconductor among industrial gainers; Limbach Holdings leads the losers https://seekingalpha.com/news/3519866-american-superconductor-among-industrial-gainers-limbach-holdings-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3519866-american-superconductor-among-industrial-gainers-limbach-holdings-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519865\" data-ts=\"1573840731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMKBY\" target=\"_blank\">AMKBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519865-maersk-moves-higher-lower-costs-lift-profitability-despite-revenue-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maersk moves higher as lower costs lift profitability despite revenue dip</a></h4><ul><li>Danish shipping giant A.P. Moeller-Maersk (<a href='https://seekingalpha.com/symbol/AMKBY' title='A.P. Møller - Mærsk A/S'>OTCPK:AMKBY</a>) closed nearly 6% higher in Europe after reporting a <a href=\"https://www.marketwatch.com/story/maersk-profit-beats-but-shipping-giant-cuts-container-outlook-on-weak-economies-trade-dispute-2019-11-15\" target=\"_blank\">31% increase in Q3 net profit</a> to $520M from $396M in the year-earlier period and above the $359M analyst consensus estimate.</li><li>Q3 EBITDA rose 14% Y/Y to $1.66B, and the company reiterates expectations for full-year EBITDA of $5.4B-$5.8B.</li><li>Maersk confirmed a 1% Y/Y drop in revenues to $10.06B, and its main shipping unit saw relatively flat revenue as a 2.1% rise in volumes was offset by a 3.6% drop in freight rates, but profitability in the unit jumped.</li><li>The rise in profitability has been <a href=\"https://www.reuters.com/article/maersk-results/update-2-maersk-keeps-down-costs-with-uncertain-container-traffic-outlook-idUSL8N27V1GE\" target=\"_blank\">driven by capacity management and cost controls</a>, with shipping unit costs falling 3% in the quarter.</li><li>Maersk says it expects global container demand to grow 1%-3% next year vs. 1%-2% in 2019, but \"continued weakening of global sentiment, above all in the manufacturing sector, reduces the likelihood of a growth pickup in 2020.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3519865\" data-linked=\"Maersk moves higher as lower costs lift profitability despite revenue dip\" data-tweet=\"$AMKBY $AMKAF $AMKBF - Maersk moves higher as lower costs lift profitability despite revenue dip https://seekingalpha.com/news/3519865-maersk-moves-higher-lower-costs-lift-profitability-despite-revenue-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3519865-maersk-moves-higher-lower-costs-lift-profitability-despite-revenue-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519864\" data-ts=\"1573840724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519864-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers: </strong>Akerna (NASDAQ:<a href='https://seekingalpha.com/symbol/KERN' title='Akerna Corp.'>KERN</a>) <font color=\"green\">+47%</font>.</li><li>Mmtec (NASDAQ:<a href='https://seekingalpha.com/symbol/MTC' title='Mmtec, Inc.'>MTC</a>) <font color=\"green\">+36%</font>.</li><li>Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"green\">+32%</font>.</li><li>Farfetch (NYSE:<a href='https://seekingalpha.com/symbol/FTCH' title='Farfetch Limited'>FTCH</a>) <font color=\"green\">+29%</font>.</li><li>Kaleido BioSciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KLDO' title='Kaleido BioSciences, Inc.'>KLDO</a>) <font color=\"green\">+21%</font>.</li><li>T2 Biosystems (NASDAQ:<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems, Inc.'>TTOO</a>) <font color=\"green\">+20%</font>.</li><li>Intelsat S.A. (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) <font color=\"green\">+18%</font>.</li><li>China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>) <font color=\"green\">+18%</font>.</li><li>nLIGHT (NASDAQ:<a href='https://seekingalpha.com/symbol/LASR' title='nLIGHT, Inc.'>LASR</a>) <font color=\"green\">+16%</font>.</li><li>CSS Industries (NYSE:<a href='https://seekingalpha.com/symbol/CSS' title='CSS Industries, Inc.'>CSS</a>) <font color=\"green\">+15%</font>.</li> <li><strong>Losers: </strong>resTORbio (NASDAQ:<a href='https://seekingalpha.com/symbol/TORC' title='resTORbio, Inc.'>TORC</a>) <font color=\"red\">-87%</font>.</li><li>The McClatchy (NYSEMKT:<a href='https://seekingalpha.com/symbol/MNI' title='The McClatchy Company'>MNI</a>) <font color=\"red\">-52%</font>.</li><li>Anchiano Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ANCN' title='Anchiano Therapeutics Ltd'>ANCN</a>) <font color=\"red\">-36%</font>.</li><li>Agile Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a>) <font color=\"red\">-34%</font>.</li><li>SandRidge Permian Trust (NYSE:<a href='https://seekingalpha.com/symbol/PER' title='SandRidge Permian Trust'>PER</a>) <font color=\"red\">-34%</font>.</li><li>Limbach Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LMB' title='Limbach Holdings, Inc.'>LMB</a>) <font color=\"red\">-35%</font>.</li><li>AeroCentury (NYSEMKT:<a href='https://seekingalpha.com/symbol/ACY' title='AeroCentury Corp.'>ACY</a>) <font color=\"red\">-31%</font>.</li><li>RAVE Restaurant Group (NASDAQ:<a href='https://seekingalpha.com/symbol/RAVE' title='RAVE Restaurant Group, Inc.'>RAVE</a>) <font color=\"red\">-23%</font>.</li><li>Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-19%</font>.</li><li>Q&amp;K International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/QK' title='Q&K International Group Limited'>QK</a>) <font color=\"red\">-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3519864\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$KERN $MTC $MLNT - Microcaps mostly among midday movers https://seekingalpha.com/news/3519864-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3519864-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519856\" data-ts=\"1573838323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNP\" target=\"_blank\">CNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519856-centerpoint-energy-slammed-downgrades-four-wall-street-firms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CenterPoint Energy slammed with downgrades at four Wall Street firms</a></h4><ul><li>CenterPoint Energy (<a href='https://seekingalpha.com/symbol/CNP' title='CenterPoint Energy, Inc.'>CNP</a> <font color='red'>-4.9%</font>) is today's biggest decliner on the S&amp;P 500 and sinks to a 52-week low after BofA Merrill Lynch, Credit Suisse, Guggenheim and SunTrust RH all downgrade the stock to Neutral or Hold from Buy.</li><li>BAML analyst Julien Dumoulin-Smith cut CNP to Neutral from Buy with a $27 price target, saying the  outcome of the Houston Electric rate case likely will be \"<a href=\"https://thefly.com/thestreet/realmoney/index.php/CNPid2994683/CNP-CenterPoint-Energy-downgraded-to-Neutral-from-Buy-at-BofAMerrill\" target=\"_blank\">much more  punitive than expected</a>.\"</li><li>The recommendation from the Texas Public Utility Commission for a 40% equity cap and  9.25% ROE will put substantial pressure on EPS estimates, and  ring-fencing provisions would restrict the company from sending a  dividend up to the parent, Dumoulin-Smith says.</li><li>Given that the Houston case  seems to be headed for an \"unconstructive outcome,\" the BAML analyst now sees the  need for as much as $1.2B in equity in 2021, up from his prior assumption of  $1B.</li><li>CNP's average <a href=\"https://seekingalpha.com/symbol/CNP/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> and <a href=\"https://seekingalpha.com/symbol/CNP/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> are Bullish, while its <a href=\"https://seekingalpha.com/symbol/CNP/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519856\" data-linked=\"CenterPoint Energy slammed with downgrades at four Wall Street firms\" data-tweet=\"$CNP - CenterPoint Energy slammed with downgrades at four Wall Street firms https://seekingalpha.com/news/3519856-centerpoint-energy-slammed-downgrades-four-wall-street-firms?source=tweet\" data-url=\"https://seekingalpha.com/news/3519856-centerpoint-energy-slammed-downgrades-four-wall-street-firms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519855\" data-ts=\"1573838302\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519855-rhplus-7-investors-ride-buffett\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH +7% as investors ride with Buffett</a></h4><ul> <li>Shares of RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) are <font color=\"green\">up 7.05%</font> after the retailer attracted Warren Buffett as an investor. The investment is drawing a lot of attention as it was the only new long position by Berkshire Hathaway in Q3.</li><li>Analysts think the Buffett interest in RH will provide a backstop for shares on the downside.</li> <li>Volume on RH is twice normal activity just halfway through the session. The high level of short interest outstanding on RH is likely to have contributed to the volume spike.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3519488-berkshire-hathaway-takes-stake-rh\" target=\"_blank\">Berkshire Hathaway takes stake in RH</a> (Nov. 14)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3519855\" data-linked=\"RH +7% as investors ride with Buffett\" data-tweet=\"$RH - RH +7% as investors ride with Buffett https://seekingalpha.com/news/3519855-rhplus-7-investors-ride-buffett?source=tweet\" data-url=\"https://seekingalpha.com/news/3519855-rhplus-7-investors-ride-buffett\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519852\" data-ts=\"1573837463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WORX\" target=\"_blank\">WORX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519852-scworx-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SCWorx reports Q3 results</a></h4><ul><li>SCWorx (NASDAQ:<a href='https://seekingalpha.com/symbol/WORX' title='SCWorx Corp.'>WORX</a>): Q3 Adj. net loss of $0.21M.</li><li>Revenue of $1.68M (+71.4% Y/Y)</li><li>Shares <font color=\"green\">+15.31%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17701171-scworx-announces-third-quarter-2019-revenue-increased-74-percent-third-quarter-2018\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3519852\" data-linked=\"SCWorx reports Q3 results\" data-tweet=\"$WORX - SCWorx reports Q3 results https://seekingalpha.com/news/3519852-scworx-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3519852-scworx-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519851\" data-ts=\"1573837219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519851-china-automotive-leads-consumer-gainers-nautilus-and-niu-technologies-in-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Automotive leads consumer gainers; Nautilus and Niu Technologies in losers</a></h4><ul><li><b>Gainers: </b>China Automotive Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CAAS' title='China Automotive Systems, Inc.'>CAAS</a>) <font color=\"green\">+34%</font>. Vapotherm (NYSE:<a href='https://seekingalpha.com/symbol/VAPO' title='Vapotherm, Inc.'>VAPO</a>) <font color=\"green\">+13%</font>. Centric Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRC' title='Centric Brands Inc.'>CTRC</a>) <font color=\"green\">+12%</font>. Embotelladora Andina (AKO-B) <font color=\"green\">+12%</font>. XPEL (NASDAQ:<a href='https://seekingalpha.com/symbol/XPEL' title='XPEL, Inc.'>XPEL</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Niu Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NIU' title='Niu Technologies'>NIU</a>) <font color=\"red\">-8%</font>. Nautilus (NYSE:<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519851\" data-linked=\"China Automotive leads consumer gainers; Nautilus and Niu Technologies in losers\" data-tweet=\"$CAAS $VAPO $CTRC - China Automotive leads consumer gainers; Nautilus and Niu Technologies in losers https://seekingalpha.com/news/3519851-china-automotive-leads-consumer-gainers-nautilus-and-niu-technologies-in-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3519851-china-automotive-leads-consumer-gainers-nautilus-and-niu-technologies-in-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519843\" data-ts=\"1573834555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOGM\" target=\"_blank\">LOGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519843-logmeinplus-5-on-sale-talks-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LogMeIn +5% on sale talks report</a></h4><ul><li>LogMeIn (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a>) is in sale talks with interested PE firms, according to <a href=\"https://www.streetinsider.com/Hot+M+and+A/LogMeIn+%28LOGM%29+in+Deep+Talks+to+Sell+to+PE+Firms+-+Sources/16142648.html\" target=\"_blank\">StreetInsider sources</a>.</li><li>Francisco Partners, which previously made a bid to buy part of LOGM, is back in talks for the whole company. LogMeIn stakeholder Thoma Bravo is also reportedly in the talks.</li><li>LogMeIn shares are <font color=\"green\">up 5.4%</font> to $77.19.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519843\" data-linked=\"LogMeIn +5% on sale talks report\" data-tweet=\"$LOGM - LogMeIn +5% on sale talks report https://seekingalpha.com/news/3519843-logmeinplus-5-on-sale-talks-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3519843-logmeinplus-5-on-sale-talks-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519841\" data-ts=\"1573834539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TARO\" target=\"_blank\">TARO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519841-taro-pharma-up-12-on-share-buybacks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taro Pharma up 12% on share buybacks</a></h4><ul><li>Taro Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TARO' title='Taro Pharmaceutical Industries Ltd.'>TARO</a> <font color=\"green\">+12.2%</font>) <a href=\"https://seekingalpha.com/pr/17700793-taro-announces-commencement-tender-offer-repurchase-225-million-value-ordinary-shares\" target=\"_blank\">commences </a>a <a href=\"https://www.laurelhill.com/dutch-auctions\" target=\"_blank\">Dutch Auction</a> tender offer for up to $225M of its ordinary shares at prices between $80 - 92. The company says the offer, representing 6.3 - 7.3% of its outstanding stock, is fully subscribed.</li><li>The offer expiration date is 5:00 pm ET on Monday, December 16.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519841\" data-linked=\"Taro Pharma up 12% on share buybacks\" data-tweet=\"$TARO - Taro Pharma up 12% on share buybacks https://seekingalpha.com/news/3519841-taro-pharma-up-12-on-share-buybacks?source=tweet\" data-url=\"https://seekingalpha.com/news/3519841-taro-pharma-up-12-on-share-buybacks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519837\" data-ts=\"1573833935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519837-plus-therapeutics-leads-healthcare-gainers-celsion-and-restorbio-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plus Therapeutics leads healthcare gainers; Celsion and resTORbio among losers</a></h4><ul><li><b>Gainers: </b>Plus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTV' title='Plus Therapeutics, Inc.'>PSTV</a>) <font color=\"green\">+23%</font>. Kaleido BioSciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KLDO' title='Kaleido BioSciences, Inc.'>KLDO</a>) <font color=\"green\">+17%</font>. PolarityTE (NASDAQ:<a href='https://seekingalpha.com/symbol/PTE' title='PolarityTE, Inc.'>PTE</a>) <font color=\"green\">+14%</font>. T2 Biosystems (NASDAQ:<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems, Inc.'>TTOO</a>) <font color=\"green\">+13%</font>. Taro Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TARO' title='Taro Pharmaceutical Industries Ltd.'>TARO</a>) <font color=\"green\">+12%</font>.</li><li><b>Losers: </b>resTORbio (NASDAQ:<a href='https://seekingalpha.com/symbol/TORC' title='resTORbio, Inc.'>TORC</a>) <font color=\"red\">-84%</font>. Anchiano Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ANCN' title='Anchiano Therapeutics Ltd'>ANCN</a>) <font color=\"red\">-40%</font>. Agile Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a>) <font color=\"red\">-27%</font>. Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-22%</font>. Celsion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519837\" data-linked=\"Plus Therapeutics leads healthcare gainers; Celsion and resTORbio among losers\" data-tweet=\"$PSTV $KLDO $PTE - Plus Therapeutics leads healthcare gainers; Celsion and resTORbio among losers https://seekingalpha.com/news/3519837-plus-therapeutics-leads-healthcare-gainers-celsion-and-restorbio-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3519837-plus-therapeutics-leads-healthcare-gainers-celsion-and-restorbio-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519821\" data-ts=\"1573830800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHR\" target=\"_blank\">DHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519821-danaher-to-launch-exchange-offer-involving-remaining-envista-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Danaher to launch exchange offer involving remaining Envista stake</a></h4><ul><li>Danaher (<a href='https://seekingalpha.com/symbol/DHR' title='Danaher Corporation'>DHR</a> <font color=\"green\">+4.2%</font>) jumps at the open after announcing it will begin an <a href=\"https://seekingalpha.com/pr/17700688-danaher-will-commence-exchange-offer-related-divestiture-remaining-interest-envista-split\" target=\"_blank\">exchange offer</a> related to the splitoff of its remaining interest in Envista (<a href='https://seekingalpha.com/symbol/NVST' title='Envista Holdings Corporation'>NVST</a> <font color=\"red\">-3.6%</font>).</li><li>DHR says the exchange offer will permit shareholders to  exchange all or part of their DHR common shares for  NVST common shares at a 7% discount.</li><li>NVST completed its IPO <a href=\"https://seekingalpha.com/news/3500033-envista-prices-ipo-22\" target=\"_blank\">in September</a>,  with DHR retaining an 80.6% ownership interest in the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519821\" data-linked=\"Danaher to launch exchange offer involving remaining Envista stake\" data-tweet=\"$DHR $NVST - Danaher to launch exchange offer involving remaining Envista stake https://seekingalpha.com/news/3519821-danaher-to-launch-exchange-offer-involving-remaining-envista-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3519821-danaher-to-launch-exchange-offer-involving-remaining-envista-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519810\" data-ts=\"1573829591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FND\" target=\"_blank\">FND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519810-floor-decor-slips-after-block-trade-priced\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Floor &amp; Decor slips after block trade priced</a></h4><ul> <li>Floor &amp; Decor (<a href='https://seekingalpha.com/symbol/FND' title='Floor & Decor Holdings, Inc.'>FND</a> <font color='red'>-1.5%</font>) trades lower after pricing a block trade of 7.1M shares at $44.25 per share.</li> <li>Shares of FND are still up over 70% YTD.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3519810\" data-linked=\"Floor &amp; Decor slips after block trade priced\" data-tweet=\"$FND - Floor &amp; Decor slips after block trade priced https://seekingalpha.com/news/3519810-floor-decor-slips-after-block-trade-priced?source=tweet\" data-url=\"https://seekingalpha.com/news/3519810-floor-decor-slips-after-block-trade-priced\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519807\" data-ts=\"1573828947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUM\" target=\"_blank\">HUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519807-trump-set-to-announce-updated-hospital-insurer-transparency-rule-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump set to announce updated hospital/insurer transparency rule today</a></h4><ul><li>Hospital operators and health insurers may experience volatility today when the Trump administration releases its updated price transparency rule at 2 pm ET.</li><li>On November 3, the White House <a href=\"https://seekingalpha.com/news/3513423-white-house-delays-hospital-transparency-rule\" target=\"_blank\">announced </a>that it was postponing implementation to allow time to include the latter.</li><li>Hospital groups vociferously oppose the rule, aimed at driving costs down, citing the \"trade secret\" nature of negotiated rates with payers.</li><li>Selected tickers: Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"green\">+0.3%</font>), Universal Health Services (<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services, Inc.'>UHS</a> <font color=\"green\">+0.2%</font>), Tenet Healthcare (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color=\"green\">+0.4%</font>), HCA Healthcare (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Healthcare, Inc.'>HCA</a> <font color=\"red\">-0.1%</font>), Community Health Systems (<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color=\"green\">+3.1%</font>), UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"green\">+0.3%</font>), WellCare Health Plans (<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color=\"red\">-0.2%</font>), Molina Healthcare (<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color=\"green\">+0.6%</font>), Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"green\">+0.2%</font>), Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"red\">-0.3%</font>), Anthem (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"red\">-0.6%</font>), CVS Health (<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a> <font color=\"green\">+0.6%)</font></li><li><strong>Update</strong>: Hospital and health insurance stocks are firmly in the green approaching the last hour of the session. President Trump <a href=\"https://www.cnbc.com/2019/11/15/health-care-stocks-rise-as-trump-talks-new-price-disclosure-rules-for-hospitals-and-insurers.html?__source=twitter%7Cmain\" target=\"_blank\">announced </a>the new rule that will require hospitals to disclose their standard charges for services, negotiated prices with insurers and the discounted price the institution is willing to accept from a patient. The rule is expected to be enacted in 2021. Legal challenges are a certainty in the meantime.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519807\" data-linked=\"Trump set to announce updated hospital/insurer transparency rule today\" data-tweet=\"$HUM $UHS $THC - Trump set to announce updated hospital/insurer transparency rule today https://seekingalpha.com/news/3519807-trump-set-to-announce-updated-hospital-insurer-transparency-rule-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3519807-trump-set-to-announce-updated-hospital-insurer-transparency-rule-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>91&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519804\" data-ts=\"1573828210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRX\" target=\"_blank\">VLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519804-valeritas-up-9-premarket-on-additional-positive-v-go-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeritas up 9% premarket on additional positive V-Go data</a></h4><ul><li>Thinly traded nano cap Valeritas Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>) is up <font color=\"green\">9% </font>premarket on modest volume in reaction to <a href=\"https://seekingalpha.com/pr/17700721-valeritas-v-go-wearable-insulin-delivery-device-demonstrates-reductions-a1c-daily-insulin\" target=\"_blank\">new data</a> on its V-Go Wearable Insulin Delivery device. The results were presented at the Annual Diabetes Technology Meeting in Maryland.</li><li>Real-world data from 122 patients with uncontrolled type 2 diabetes (T2D) with HbA1c levels above 7.0% (key threshold for diabetics to manage their condition) showed mean reductions of 1.3% after median duration of five months of V-Go use.</li><li><a href=\"https://www.go-vgo.com/how-v-go-works/what-is-v-go/\" target=\"_blank\">V-Go</a> is a disposable insulin delivery device (patch) that is placed on the skin where it delivers basal/bolus insulin over a 24-hour period.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519804\" data-linked=\"Valeritas up 9% premarket on additional positive V-Go data\" data-tweet=\"$VLRX - Valeritas up 9% premarket on additional positive V-Go data https://seekingalpha.com/news/3519804-valeritas-up-9-premarket-on-additional-positive-v-go-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3519804-valeritas-up-9-premarket-on-additional-positive-v-go-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519801\" data-ts=\"1573827757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519801-amat-jcp-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMAT, JCP among premarket gainers</a></h4><ul><li>Plus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTV' title='Plus Therapeutics, Inc.'>PSTV</a>) <font color=\"green\">+30%</font> after <a href=\"https://seekingalpha.com/news/3519437-plus-therapeutics-eps-beats-5_82\" target=\"_blank\">Q3 results</a>.</li><li>Farfetch (NYSE:<a href='https://seekingalpha.com/symbol/FTCH' title='Farfetch Limited'>FTCH</a>) <font color=\"green\">+28%</font> after <a href=\"https://seekingalpha.com/news/3519553-farfetch-eps-beats-0_02-beats-revenue\" target=\"_blank\">Q3 results</a>.</li><li>RadNet (NASDAQ:<a href='https://seekingalpha.com/symbol/RDNT' title='RadNet, Inc.'>RDNT</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/news/3519613-radnet-plus-9-percent-addition-smallcap-600\" target=\"_blank\">addition to SmallCap 600</a>.</li><li>BioCryst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a>) <font color=\"green\">+11%</font>.</li><li>J. C. Penney Company (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J. C. Penney Company, Inc.'>JCP</a>) <font color=\"green\">+10%</font> after <a href=\"https://seekingalpha.com/news/3519705-j-c-penney-eps-beats-0_24-beats-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Valeritas Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/pr/17700721-valeritas-v-go-wearable-insulin-delivery-device-demonstrates-reductions-a1c-daily-insulin\" target=\"_blank\">positive clinical outcomes</a> for patients with type 2 diabetes who switched insulin therapy to V-Go from a basal-only, basal-bolus, or premix insulin regimen.</li><li>Progyny (NASDAQ:<a href='https://seekingalpha.com/symbol/PGNY' title='Progyny, Inc.'>PGNY</a>) <font color=\"green\">+8%</font>.</li><li>Sociedad Quimica y Minera de Chile S.A. (NYSE:<a href='https://seekingalpha.com/symbol/SQM' title='Sociedad Química y Minera de Chile S.A.'>SQM</a>) <font color=\"green\">+8%</font>.</li><li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) <font color=\"green\">+7%</font> as <a href=\"https://seekingalpha.com/news/3519488-berkshire-hathaway-takes-stake-rh\" target=\"_blank\">Berkshire Hathaway takes stake</a> in the company.</li><li>Acasti Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma Inc.'>ACST</a>) <font color=\"green\">+7%</font> following Amarin's <a href=\"https://seekingalpha.com/news/3519626-acasti-and-matinas-perk-positive-ad-com-vote-amarins-vascepa\" target=\"_blank\">FDA panel win</a> to expand the label for high triglyceride med Vascepa (icosapent ethyl) to include a CV benefit claim.</li><li>Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) <font color=\"green\">+7%</font>. after <a href=\"https://seekingalpha.com/news/3519424-applied-materials-eps-beats-0_04-beats-revenue\" target=\"_blank\">Q4 earnings</a> and <a href=\"https://seekingalpha.com/news/3519758-amat-gets-street-high-target-earnings\" target=\"_blank\">positive analyst upgrade</a>.</li><li>Amarin Corporation plc (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) <font color=\"green\">+7%</font> on positive vote from an FDA advisory committee backing a CV benefit claim for Vascepa (icosapent ethyl).</li><li>ShockWave Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/SWAV' title='ShockWave Medical, Inc.'>SWAV</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3519680-shockwave-medical-prices-stock-offering-36_25\" target=\"_blank\">pricing</a> of stock offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519801\" data-linked=\"AMAT, JCP among premarket gainers\" data-tweet=\"$PSTV $FTCH $RDNT - AMAT, JCP among premarket gainers https://seekingalpha.com/news/3519801-amat-jcp-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3519801-amat-jcp-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519793\" data-ts=\"1573827264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANCN\" target=\"_blank\">ANCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519793-anchiano-bails-on-bladder-cancer-gene-therapy-shares-down-33-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anchiano bails on bladder cancer gene therapy; shares down 33% premarket</a></h4><ul><li>Ultra-thinly traded nano cap Anchiano Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ANCN' title='Anchiano Therapeutics Ltd'>ANCN</a>) slumps <font color=\"red\">33%</font> premarket on light volume in reaction to its decision to <a href=\"https://seekingalpha.com/pr/17700852-anchiano-discontinues-phase-2-codex-study-evaluating-inodiftagene-vixteplasmid-patients-non\" target=\"_blank\">terminate</a> a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03719300?term=anchiano&amp;draw=2&amp;rank=1\" target=\"_blank\">Codex</a>, evaluating gene therapy inodiftagene vixteplasmid in patients with BCG-unresponsive non-muscle-invasive bladder cancer &#40;NMIBC&#41;.</li><li>The company decided to pull the plug due to the low probability of success. It will focus its resources on its small-molecule pan-RAS inhibitor and PDE10/β-catenin inhibitor programs.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519793\" data-linked=\"Anchiano bails on bladder cancer gene therapy; shares down 33% premarket\" data-tweet=\"$ANCN - Anchiano bails on bladder cancer gene therapy; shares down 33% premarket https://seekingalpha.com/news/3519793-anchiano-bails-on-bladder-cancer-gene-therapy-shares-down-33-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3519793-anchiano-bails-on-bladder-cancer-gene-therapy-shares-down-33-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519791\" data-ts=\"1573827202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519791-acb-ln-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ACB, LN among premarket losers</a></h4><ul><li>ResTORbio (NASDAQ:<a href='https://seekingalpha.com/symbol/TORC' title='resTORbio, Inc.'>TORC</a>) <font color=\"red\">-78%</font> after lead candidate <a href=\"https://seekingalpha.com/news/3519720-restorbio-74-percent-premarket-lead-candidate-flunks-study\" target=\"_blank\">flunks</a> study.</li><li>Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-32%</font> on <a href=\"https://seekingalpha.com/pr/17700880-tonix-pharmaceuticals-prices-9_0-million-public-offering\" target=\"_blank\">pricing</a> $9M public offering.</li><li>Agile Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AGRX' title='Agile Therapeutics, Inc.'>AGRX</a>) <font color=\"red\">-31%</font> after FDA <a href=\"https://seekingalpha.com/news/3519524-fda-extends-action-date-agiles-twirla-shares-39-percent-hours\" target=\"_blank\">extends action date</a> for Twirla.</li><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) <font color=\"red\">-14%</font> on <a href=\"https://seekingalpha.com/news/3519583-aurora-cannabis-eps-beats-c-0_06-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Eros International (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) <font color=\"red\">-13%</font> on <a href=\"https://seekingalpha.com/news/3519722-eros-international-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li>Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"red\">-12%</font> on <a href=\"https://seekingalpha.com/news/3519578-village-farms-international-eps-misses-0_03-beats-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>LINE (NYSE:<a href='https://seekingalpha.com/symbol/LN' title='LINE Corporation'>LN</a>) <font color=\"red\">-9%</font>.</li><li>Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"red\">-6%</font>.</li><li>TrovaGene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3519791\" data-linked=\"ACB, LN among premarket losers\" data-tweet=\"$TORC $TNXP $AGRX - ACB, LN among premarket losers https://seekingalpha.com/news/3519791-acb-ln-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3519791-acb-ln-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519789\" data-ts=\"1573826528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAS\" target=\"_blank\">MAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519789-masco-to-sell-cabinetry-unit-in-1b-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Masco to sell cabinetry unit in $1B deal</a></h4><ul><li>Masco (NYSE:<a href='https://seekingalpha.com/symbol/MAS' title='Masco Corporation'>MAS</a>) <font color=\"green\">+1.8%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17700768-masco-corporation-announces-signing-definitive-agreement-sell-masco-cabinetry\" target=\"_blank\">agreeing to sell</a> its Masco Cabinetry business to ACProducts Inc. in a deal valued at $1B in cash and preferred stock.</li><li>The company said earlier this year that it planned to divest its cabinetry and window businesses; just <a href=\"https://seekingalpha.com/news/3516351-masco-offloads-milgard-windows-doors\" target=\"_blank\">last week</a>, it completed the sale of its Milgard Windows and Doors subsidiary for $725M.</li><li>MAS also forecasts full-year EPS from continuing operations of $2.12-$2.16 and adjusted EPS of $2.19-$2.23.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519789\" data-linked=\"Masco to sell cabinetry unit in $1B deal\" data-tweet=\"$MAS - Masco to sell cabinetry unit in $1B deal https://seekingalpha.com/news/3519789-masco-to-sell-cabinetry-unit-in-1b-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3519789-masco-to-sell-cabinetry-unit-in-1b-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519768\" data-ts=\"1573825890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAYS\" target=\"_blank\">PAYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519768-paysign-lands-new-bull-shares-up-2_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PaySign lands a new bull; shares up 2.7%</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li><li>The stock's had a big upside move over the last year, but investors have a rare buy-the-dip opportunity, says D.A. Davidson, initiating PaySign (NASDAQ:<a href='https://seekingalpha.com/symbol/PAYS' title='PaySign, Inc.'>PAYS</a>) with a Buy rating and Street-high $16 price target (more than <font color=\"green\">40% upside</font> from yesterday's close).</li><li>The company remains one of the stand-out small-cap growth names in payments, says Davidson, with nearly 27% of the float sold short.</li><li>Shares are <font color=\"green\">up 2.7%</font> premarket to $11.59.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519768\" data-linked=\"PaySign lands a new bull; shares up 2.7%\" data-tweet=\"$PAYS - PaySign lands a new bull; shares up 2.7% https://seekingalpha.com/news/3519768-paysign-lands-new-bull-shares-up-2_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3519768-paysign-lands-new-bull-shares-up-2_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519763\" data-ts=\"1573825768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/A\" target=\"_blank\">A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519763-stifel-likes-illumina-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel likes Illumina in premarket analyst action</a></h4><ul><li>Agilent (NYSE:<a href='https://seekingalpha.com/symbol/A' title='Agilent Technologies, Inc.'>A</a>) initiated with Hold rating and $85 (11% upside) price target at Stifel.</li><li>Avantor (NYSE:<a href='https://seekingalpha.com/symbol/AVTR' title='Avantor, Inc.'>AVTR</a>) initiated with Hold rating and $16 (flat) price target at Stifel.</li><li>Bio-techne (NASDAQ:<a href='https://seekingalpha.com/symbol/TECH' title='Bio-Techne Corporation'>TECH</a>) initiated with Bur rating and $235 (15% upside) price target at Stifel.</li><li>Bruker (NASDAQ:<a href='https://seekingalpha.com/symbol/BRKR' title='Bruker Corporation'>BRKR</a>) initiated with Hold rating and $53 (8% upside) price target at Stifel.</li><li>Danaher (NYSE:<a href='https://seekingalpha.com/symbol/DHR' title='Danaher Corporation'>DHR</a>) initiated with Hold rating and $150 (10% upside) price target at Stifel.</li><li>Exact Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/EXAS' title='Exact Sciences Corporation'>EXAS</a>) initiated with Buy rating and $110 (39% upside) price target at Stifel. Shares up <font color=\"green\">2%</font> premarket.</li><li>Genocea Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GNCA' title='Genocea Biosciences, Inc.'>GNCA</a>) initiated with Outperform rating and $7 (217% upside) price target at SVB Leerink. Shares up <font color=\"green\">5%</font> premarket.</li><li>Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>) initiated with Buy rating and $345 (15% upside) price target at Stifel.</li><li>Mettler-Toledo (NYSE:<a href='https://seekingalpha.com/symbol/MTD' title='Mettler-Toledo International Inc.'>MTD</a>) initiated with Hold rating and $790 (11% upside) price target at Stifel.</li><li>NanoString Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NSTG' title='NanoString Technologies, Inc.'>NSTG</a>) initiated with Buy rating and $28 (18% upside) price target at Stifel.</li><li>PerkinElmer (NYSE:<a href='https://seekingalpha.com/symbol/PKI' title='PerkinElmer, Inc.'>PKI</a>) initiated with Buy rating and $102 (16% upside) price target at Stifel.</li><li>QIAGEN (NYSE:<a href='https://seekingalpha.com/symbol/QGEN' title='QIAGEN N.V.'>QGEN</a>) initiated with Hold rating and $33 (11% downside risk) price target at Stifel. Shares up <font color=\"green\">1% </font>premarket.</li><li>Repligen (NASDAQ:<a href='https://seekingalpha.com/symbol/RGEN' title='Repligen Corporation'>RGEN</a>) initiated with Buy rating and $105 (29% upside) price target at Stifel.</li><li>Waters (NYSE:<a href='https://seekingalpha.com/symbol/WAT' title='Waters Corporation'>WAT</a>) initiated with Hold rating and $210 (2% downside risk) price target at Stifel.</li><li>Aurora Cannabis (NYSE:<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>) upgraded to Overweight with a C$5.85 (34% upside) price target at Cantor Fitzgerald. Shares down <font color=\"red\">13%</font> premarket in U.S.</li><li>BioCryst Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BCRX' title='BioCryst Pharmaceuticals, Inc.'>BCRX</a>) upgraded to Buy with a $4 (152% upside) price target at BofA Merrill Lynch. Shares up <font color=\"green\">12%</font> premarket.</li><li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) downgraded to Hold with a C$25 (19% upside) price target at Canaccord Genuity. Shares down <font color=\"red\">3%</font> premarket in U.S.</li><li>Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a>) downgraded to Market Perform at Raymond James. Shares down <font color=\"red\">3%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519763\" data-linked=\"Stifel likes Illumina in premarket analyst action\" data-tweet=\"$A $AVTR $TECH - Stifel likes Illumina in premarket analyst action https://seekingalpha.com/news/3519763-stifel-likes-illumina-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3519763-stifel-likes-illumina-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519751\" data-ts=\"1573825184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519751-netflix-eyes-all-original-content-future\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix eyes all-original content future</a></h4><ul> <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) Chief Content Officer Ted Sarandos says he was <a href=\"https://www.wsj.com/articles/netflixs-content-chief-says-nothing-has-changed-with-disney-launch-11573759213\" target=\"_blank\">surprised</a> that it took so long for Disney (NYSE:<a href='https://seekingalpha.com/symbol/DIS' title='The Walt Disney Company'>DIS</a>) and other media giants to emerge as streaming competitors.</li> <li>\"We figured at some point everybody would get into this,\" observes Sarandos.</li> <li>Looking ahead, Sarandos envisions an environment where Netflix will rely on its own content completely, instead of licensing programming. That expectation explains the huge push by Netflix into developing original series and movies.</li> <li>Shares of Netflix are <font color=\"green\">up 0.44%</font> premarket to $290.89.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3519751\" data-linked=\"Netflix eyes all-original content future\" data-tweet=\"$NFLX $NFLX $DIS - Netflix eyes all-original content future https://seekingalpha.com/news/3519751-netflix-eyes-all-original-content-future?source=tweet\" data-url=\"https://seekingalpha.com/news/3519751-netflix-eyes-all-original-content-future\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>141&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519747\" data-ts=\"1573824975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519747-barclays-outlines-how-uber-double\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays outlines how Uber could double</a></h4><ul><li>Barclays analyst Ross Sandler thinks Uber (NYSE:<a href='https://seekingalpha.com/symbol/UBER' title='Uber Technologies, Inc.'>UBER</a>) is \"one major announcement away\" from a positive narrative change heading into the new year.</li><li>The note is titled \"How UBER Can Double.\"</li><li>Ross notes the +60% re-rating when Delivery Hero <a href=\"https://www.deliveryhero.com/delivery-hero-sells-food-delivery-operations-germany-takeaway-com-cash-shares-reinvests-growth/\" target=\"_blank\">sold</a> its German food delivery operations to Takeaway.com in late 2018. A similar \"truce\" is likely happening now in the UK with Just Eat and Takeaway. Sandler sees a similar path for Uber.</li><li>Source: <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">Notable Calls</a>.</li><li>Uber shares are <font color=\"green\">up 1.2%</font> pre-market to $26.29.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519747\" data-linked=\"Barclays outlines how Uber could double\" data-tweet=\"$UBER - Barclays outlines how Uber could double https://seekingalpha.com/news/3519747-barclays-outlines-how-uber-double?source=tweet\" data-url=\"https://seekingalpha.com/news/3519747-barclays-outlines-how-uber-double\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519725\" data-ts=\"1573823351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519725-amarin-up-7-after-positive-ad-com-vote-on-cv-claim-for-vascepa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin up 7% after positive Ad Com vote on CV claim for Vascepa</a></h4><ul><li>Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) is up <font color=\"green\">7%</font> premarket on robust volume after yesterday's <a href=\"https://seekingalpha.com/news/3519441-fda-ad-com-thumbs-cv-benefit-amarins-vascepa\" target=\"_blank\">positive vote</a> from an FDA advisory committee backing a CV benefit claim for Vascepa (icosapent ethyl).</li></ul><div class=\"tiny-share-widget\" data-id=\"3519725\" data-linked=\"Amarin up 7% after positive Ad Com vote on CV claim for Vascepa\" data-tweet=\"$AMRN - Amarin up 7% after positive Ad Com vote on CV claim for Vascepa https://seekingalpha.com/news/3519725-amarin-up-7-after-positive-ad-com-vote-on-cv-claim-for-vascepa?source=tweet\" data-url=\"https://seekingalpha.com/news/3519725-amarin-up-7-after-positive-ad-com-vote-on-cv-claim-for-vascepa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519724\" data-ts=\"1573823251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRUB\" target=\"_blank\">GRUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519724-grubhub-up-5-after-two-notch-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GrubHub up 5% after two-notch upgrade</a></h4><ul><li>Details aren't yet available, but Barclays is doing some bottom-picking in beleaguered GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='Grubhub Inc.'>GRUB</a>), boosting to Overweight from Underweight.</li><li>The note reportedly has a number of recommendations on how the company might improve operations and its stock price.</li><li>Shares are <font color=\"green\">up 4.8%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519724\" data-linked=\"GrubHub up 5% after two-notch upgrade\" data-tweet=\"$GRUB - GrubHub up 5% after two-notch upgrade https://seekingalpha.com/news/3519724-grubhub-up-5-after-two-notch-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3519724-grubhub-up-5-after-two-notch-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519720\" data-ts=\"1573823040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TORC\" target=\"_blank\">TORC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519720-restorbio-down-74-premarket-after-lead-candidate-flunks-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ResTORbio down 74% premarket after lead candidate flunks study</a></h4><ul><li>Thinly traded micro cap resTORbio (NASDAQ:<a href='https://seekingalpha.com/symbol/TORC' title='resTORbio, Inc.'>TORC</a>) plummets <font color=\"red\">74% </font>premarket on increased volume in reaction to its <a href=\"https://seekingalpha.com/pr/17700727-restorbio-announces-phase-3-protector-1-trial-rtb101-clinically-symptomatic-respiratory\" target=\"_blank\">announcement </a>that lead candidate RTB101 failed to achieve the primary endpoint in a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT04139915?term=restorbio&amp;draw=2&amp;rank=1\" target=\"_blank\">PROTECTOR 1</a>, evaluating its ability to prevent clinically symptomatic respiratory illness in patients at least 65 years old.</li><li>The company has terminated development of the TORC1 inhibitor for this indication.</li><li>A conference call is in process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519720\" data-linked=\"ResTORbio down 74% premarket after lead candidate flunks study\" data-tweet=\"$TORC - ResTORbio down 74% premarket after lead candidate flunks study https://seekingalpha.com/news/3519720-restorbio-down-74-premarket-after-lead-candidate-flunks-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3519720-restorbio-down-74-premarket-after-lead-candidate-flunks-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519711\" data-ts=\"1573822003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519711-roku-boosted-on-positioning-black-friday-sharesplus-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku boosted on positioning, Black Friday; shares +2%</a></h4><ul><li>Bank of America maintains a Buy rating on Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a>) and raises the target by $10 to $160. The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/ROKU/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Analyst Ziv Israel says lower device ASPs and new smart TV products have Roku well positioned for \"outsized Q4 account growth.\"</li><li>The analyst notes that Roku's <a href=\"https://seekingalpha.com/pr/17699445-roku-announces-limited-edition-onn-roku-tv-limited-edition-18-roku-se-player-exclusively\" target=\"_blank\">recently announced</a> Black Friday deals \"will be highly competitive.\"</li><li>Roku shares are <font color=\"green\">up 2.3%</font> pre-market to $152.11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519711\" data-linked=\"Roku boosted on positioning, Black Friday; shares +2%\" data-tweet=\"$ROKU - Roku boosted on positioning, Black Friday; shares +2% https://seekingalpha.com/news/3519711-roku-boosted-on-positioning-black-friday-sharesplus-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3519711-roku-boosted-on-positioning-black-friday-sharesplus-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519710\" data-ts=\"1573821743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519710-j-c-penneyplus-13-after-narrowing-quarterly-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J. C. Penney +13% after narrowing quarterly loss</a></h4><ul> <li>J. C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J. C. Penney Company, Inc.'>JCP</a>) reports comparable store sales fell 9.3% in <a href=\"https://seekingalpha.com/pr/17700754-jcpenney-reports-third-quarter-2019-financial-results\" target=\"_blank\">Q3</a>. On an adjusted basis, including categories exited, comparable store sales were down 6.6%.</li> <li>Cost of goods sold improved to 64.6% of sales from 68.1% a year ago. The company says the 350-basis point improvement was primarily driven by an increase in both store and online selling margins, improved shrink as a percent of net sales and the exit from the major appliance and in-store furniture categories earlier this year.</li> <li>JCP's net loss for the quarter narrowed to $97M from $164M a year ago.</li> <li>The department store operator ended the quarter with an inventory position down 9.0% from a year ago.</li> <li>Looking ahead, J. C. Penney anticipates comparable store sales to fall in a range of -7.0% to -8.0% for the full year.</li> <li>Shares of JCP are <font color=\"green\">up 12.73%</font> premarket to $1.24.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3519705-j-c-penney-eps-beats-0_24-beats-revenue\" target=\"_blank\">J. C. Penney EPS beats by $0.24, beats on revenue</a> (Nov. 15)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3519710\" data-linked=\"J. C. Penney +13% after narrowing quarterly loss\" data-tweet=\"$JCP - J. C. Penney +13% after narrowing quarterly loss https://seekingalpha.com/news/3519710-j-c-penneyplus-13-after-narrowing-quarterly-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3519710-j-c-penneyplus-13-after-narrowing-quarterly-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519707\" data-ts=\"1573821283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519707-qualcommplus-1_6-mizuho-turns-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm +1.6% as Mizuho turns bullish</a></h4><ul><li>Mizuho upgrades Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a>) from Neutral to Buy and raises the target by $20 to $100.</li><li>Analyst Vijay Rakesh says the company is \"well positioned\" for the expected 5G investment ramp. The growth \"should drive a better topline\" and increase margins and ASPs in 2020.</li><li>QCOM shares are <font color=\"green\">up 1.6%</font> pre-market to $91.95.</li><li>Qualcomm has a Bullish average <a href=\"https://seekingalpha.com/symbol/QCOM/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519707\" data-linked=\"Qualcomm +1.6% as Mizuho turns bullish\" data-tweet=\"$QCOM - Qualcomm +1.6% as Mizuho turns bullish https://seekingalpha.com/news/3519707-qualcommplus-1_6-mizuho-turns-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3519707-qualcommplus-1_6-mizuho-turns-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519704\" data-ts=\"1573821145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LWAY\" target=\"_blank\">LWAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519704-lifeway-foodsplus-5-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lifeway Foods +5% after earnings</a></h4><ul> <li>Shares of Lifeway Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/LWAY' title='Lifeway Foods, Inc.'>LWAY</a>) march higher in early action following the company's Q3 earnings report.</li> <li>Sales were down 2.2% during the quarter and gross profit fell 120 bps to 22.8% of sales. The margin drop was primarily due to the unfavorable impact of operating leverage that arises from lower net sales relative to fixed costs, partially offset by a reduction in variable costs.</li> <li>Looking ahead, Lifeway exec are talking up the potential of the Plantiful business. \"We are thrilled major retailers nationwide have chosen Plantiful to enhance their healthy consumable product offerings. We believe this increased distribution will lead to long-term sales growth in demographics previously unserved by Lifeway, and we look forward to adding new distribution in the future,\" states CEO Julie Smolyansky.</li><li>LWAY <font color=\"green\">+5.37%</font> premarket to $2.16.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3519542-lifeway-foods-reports-q3-results\" target=\"_blank\">Lifeway Foods reports Q3 results</a> (Nov. 14)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3519704\" data-linked=\"Lifeway Foods +5% after earnings\" data-tweet=\"$LWAY - Lifeway Foods +5% after earnings https://seekingalpha.com/news/3519704-lifeway-foodsplus-5-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3519704-lifeway-foodsplus-5-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519705\" data-ts=\"1573821145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519705-j-c-penney-eps-beats-0_24-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J. C. Penney EPS beats by $0.24, beats on revenue</a></h4><ul><li>J. C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J. C. Penney Company, Inc.'>JCP</a>): Q3 Non-GAAP EPS of -$0.30 <font color=\"green\">beats by $0.24</font>; GAAP EPS of -$0.29 <font color=\"green\">beats by $0.28</font>.</li><li>Revenue of $2.5B (-8.4% Y/Y) <font color=\"green\">beats by $70M</font>.</li><li>Shares <font color=\"green\">+10%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17700754-jcpenney-reports-third-quarter-2019-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3519705\" data-linked=\"J. C. Penney EPS beats by $0.24, beats on revenue\" data-tweet=\"$JCP - J. C. Penney EPS beats by $0.24, beats on revenue https://seekingalpha.com/news/3519705-j-c-penney-eps-beats-0_24-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3519705-j-c-penney-eps-beats-0_24-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519703\" data-ts=\"1573821136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519703-european-advisory-group-backs-mylans-generic-duoplavin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs Mylan&#39;s generic DuoPlavin</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has adopted a <a href=\"https://www.ema.europa.eu/en/medicines/human/summaries-opinion/clopidogrel-acetylsalicylic-acid-mylan\" target=\"_blank\">positive opinion</a> recommending approval of Mylan N.V.'s (NASDAQ:<a href='https://seekingalpha.com/symbol/MYL' title='Mylan N.V.'>MYL</a>) clopidogrel/acetylsalicylic acid, a generic version of Sanofi's (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) heart med DuoPlavin.</li><li>A final decision from the European Commission usually takes ~60 days.</li><li>Shares up <font color=\"green\">1%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519703\" data-linked=\"European advisory group backs Mylan&#39;s generic DuoPlavin\" data-tweet=\"$MYL $SNY - European advisory group backs Mylan&#39;s generic DuoPlavin https://seekingalpha.com/news/3519703-european-advisory-group-backs-mylans-generic-duoplavin?source=tweet\" data-url=\"https://seekingalpha.com/news/3519703-european-advisory-group-backs-mylans-generic-duoplavin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519701\" data-ts=\"1573820753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIGL\" target=\"_blank\">RIGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519701-rigel-pharma-up-10-premarket-on-chmp-nod-for-tavlesse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rigel Pharma up 10% premarket on CHMP nod for Tavlesse</a></h4><ul><li>It took an extra month, but the European Medicines Agency's advisory group CHMP has adopted a <a href=\"https://www.ema.europa.eu/en/medicines/human/summaries-opinion/tavlesse\" target=\"_blank\">positive opinion</a> recommending approval of Rigel Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/RIGL' title='Rigel Pharmaceuticals, Inc.'>RIGL</a>) Tavlesse (fostamatinib) for the treatment of primary thrombocytopenia (low blood platelets) in adult patients who have not responded to other treatments.</li><li>In October, CHMP indicated a \"<a href=\"https://seekingalpha.com/news/3506848-rigel-pharma-quite-european-application-fostamatinib\" target=\"_blank\">positive trend vote</a>.\"</li><li>Shares up <font color=\"green\">10%</font> premarket on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519701\" data-linked=\"Rigel Pharma up 10% premarket on CHMP nod for Tavlesse\" data-tweet=\"$RIGL - Rigel Pharma up 10% premarket on CHMP nod for Tavlesse https://seekingalpha.com/news/3519701-rigel-pharma-up-10-premarket-on-chmp-nod-for-tavlesse?source=tweet\" data-url=\"https://seekingalpha.com/news/3519701-rigel-pharma-up-10-premarket-on-chmp-nod-for-tavlesse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519699\" data-ts=\"1573820495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519699-jd-complus-4_7-after-beats-inline-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com +4.7% after beats, inline outlook</a></h4><ul><li>JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com, Inc.'>JD</a>)<font color=\"green\"> +4.7%</font> beats Q3 estimates and guides inline Q4 revenue guidance of $23.25-24B versus the $23.3B consensus.</li><li>Q3 net services revenue rose 47% Y/Y to $2.2B.</li><li>Adjusted EBITDA was $600.5M compared to $412.2M consensus.</li><li>Income from operations totaled $416.2M, up from $91M in last year's quarter.</li><li>Annual active customer accounts increased to 334.4M TTM. Mobile monthly active users grew 36% Y/Y.</li><li><a href=\"https://seekingalpha.com/pr/17700643-jd-com-announces-third-quarter-2019-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519699\" data-linked=\"JD.com +4.7% after beats, inline outlook\" data-tweet=\"$JD - JD.com +4.7% after beats, inline outlook https://seekingalpha.com/news/3519699-jd-complus-4_7-after-beats-inline-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3519699-jd-complus-4_7-after-beats-inline-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519681\" data-ts=\"1573818634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXTC\" target=\"_blank\">NXTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519681-nextcure-prices-stock-offering-36_75\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NextCure prices stock offering at $36.75</a></h4><ul><li>NextCure (NASDAQ:<a href='https://seekingalpha.com/symbol/NXTC' title='NextCure, Inc.'>NXTC</a>) <a href=\"https://seekingalpha.com/pr/17700594-nextcure-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of ~4.1M common shares at $36.75 per share, expected to yield gross proceeds of ~$150M. Underwriters' over-allotment is an additional ~612K shares. Closing date is November 19.</li><li>Yesterday's close was $38.55.</li><li>Shares down <font color=\"red\">1%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519681\" data-linked=\"NextCure prices stock offering at $36.75\" data-tweet=\"$NXTC - NextCure prices stock offering at $36.75 https://seekingalpha.com/news/3519681-nextcure-prices-stock-offering-36_75?source=tweet\" data-url=\"https://seekingalpha.com/news/3519681-nextcure-prices-stock-offering-36_75\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519680\" data-ts=\"1573818456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWAV\" target=\"_blank\">SWAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519680-shockwave-medical-prices-stock-offering-36_25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shockwave Medical prices stock offering at $36.25</a></h4><ul><li>Shockwave Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/SWAV' title='ShockWave Medical, Inc.'>SWAV</a>) <a href=\"https://seekingalpha.com/pr/17700592-shockwave-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of ~2.5M common shares at $36.25 per share. Underwriters' over-allotment is an additional ~372K shares. Gross proceeds should be ~$90M.</li><li>Closing date is November 19.</li><li>Yesterday's close was $36.44.</li><li>Shares up <font color=\"green\">1%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519680\" data-linked=\"Shockwave Medical prices stock offering at $36.25\" data-tweet=\"$SWAV - Shockwave Medical prices stock offering at $36.25 https://seekingalpha.com/news/3519680-shockwave-medical-prices-stock-offering-36_25?source=tweet\" data-url=\"https://seekingalpha.com/news/3519680-shockwave-medical-prices-stock-offering-36_25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519666\" data-ts=\"1573814170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JD\" target=\"_blank\">JD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519666-jd-com-eps-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JD.com EPS beats by $0.12, beats on revenue</a></h4><ul><li>JD.com (NASDAQ:<a href='https://seekingalpha.com/symbol/JD' title='JD.com, Inc.'>JD</a>): Q3 Non-GAAP EPS of $0.29 <font color=\"green\">beats by $0.12</font>; GAAP EPS of $0.06 <font color=\"red\">misses by $0.02</font>.</li><li>Revenue of $18.9B <font color=\"green\">beats by $580M</font>.</li><li>Shares <font color=\"green\">+5.36%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17700643-jd-com-announces-third-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3519666\" data-linked=\"JD.com EPS beats by $0.12, beats on revenue\" data-tweet=\"$JD - JD.com EPS beats by $0.12, beats on revenue https://seekingalpha.com/news/3519666-jd-com-eps-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3519666-jd-com-eps-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3519665\" data-ts=\"1573813232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3519665-futures-gain-on-trade-developments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures gain on trade developments</a></h4><ul><li>While major U.S. equity indexes recorded another flat close on Thursday, things are looking brighter ahead of the open, with DJIA futures pointing to <font color=\"green\">gains of more than 100 points</font>.</li><li>Trade developments... White House economic adviser Larry Kudlow signaled talks over the first phase of an agreement with China were coming down to the final stages and said the two sides in close contact.</li><li>On Thursday, China also lifted a ban on American poultry that began in 2015, after the USDA made a similar decision to allow Chinese poultry into the U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3519665\" data-linked=\"Futures gain on trade developments\" data-tweet=\"Futures gain on trade developments https://seekingalpha.com/news/3519665-futures-gain-on-trade-developments?source=tweet\" data-url=\"https://seekingalpha.com/news/3519665-futures-gain-on-trade-developments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>84&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":48,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}